Institutional flow

Institutional Flow — Scan of Oct 24, 2026

Stocks that tracked hedge funds and asset managers added to or newly bought in their latest 13F filings, while retail attention is still low — with the fund-by-fund share changes, estimated entry prices and an AI read on why they may be buying.

Next scan: tomorrow by 9:00 AM ET. A new scan is posted every Saturday by 9:00 AM ET.
5stocks qualified
5funds adding
3new positions
$3.21Bheld by those funds

AIThis scan

We compared the 2026-06-30 vs 2026-03-31 13F-HR windows across Berkshire Hathaway, Bridgewater, Renaissance Technologies, Citadel, and Two Sigma (filed 2026-08-14 and 2026-05-15 respectively). All five funds returned complete holdings. Roughly twenty manager-tickers passed the net-buyers-greater-than-sellers / ≥25% Q/Q aggregate acceleration test; the five below survived the mega-cap-retail-favorite filter, the earnings-window filter (seven other names reporting within seven trading days were cut), and the retail-attention screen. Single most surprising finding: PG&E (PCG) attracted three funds — Two Sigma, Bridgewater, and Renaissance — adding at a ~$16.80 quarter-end average, and the stock has since drifted to $12.63 on wildfire-season risk-off. That is institutional entry minus 25%, after a Q3 2026 print (Oct 22) that did not break the dividend or capex plan. Separately, Berkshire increased Delta Air Lines (DAL) +44% to 57.3M shares (~$5.4B), a sizable Buffett-return-to-airlines move; we filtered DAL from this list because the headline has been widely circulated and the "quiet" setup is gone, but it is worth noting in the broader slow-money picture.

How this scan was run

Pulled 13F-HR filings for the five configured funds via SEC EDGAR; aggregated by CUSIP across split-line entries, excluded all putCall="Put" positions, counted "Call" lines as long exposure. Qualifier required net buyers > net sellers across the watchlist with ≥25% Q/Q aggregate share increase, OR ≥2 funds opening a new position; single-fund >80% block buys excluded unless the filer was Berkshire. Weighted Berkshire and Bridgewater (slower-moving, thesis-driven) higher; Renaissance, Citadel, and Two Sigma treated as partial-signal because intra-quarter turnover makes 13F a lagged read. CUSIP→ticker resolved via standard SEC identifiers (no dual-class ambiguity in the surviving set). Mega-cap retail favorites filtered: GOOG and GOOGL excluded despite Berkshire's +658%/+45% adds. Earnings-window filter cut Suncor (Nov 3), Intercontinental Exchange (Oct 29), TechnipFMC (Oct 29), Edwards Lifesciences (~Oct 28), and Weyerhaeuser (Oct 29) — all reporting within 7 trading days of 2026-10-24. Avg entry price is derived from valueUsd ÷ sharesHeld at the 2026-06-30 close, aggregated across supporting funds — this is a quarter-end mark, not a true cost basis.

#1

MDT

Medtronic PLC
Health CareMkt cap $121.0BNext earnings Nov 17, 2026
Price
$95.41
Est. fund entry
$78.23+22.0%
Shares held
13.1M
Position value
$1.02B
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies—3.17MNew position
Citadel Advisors2.45M6.20M+153.1%
Bridgewater Associates255.2K482.5K+89.0%
Two Sigma Investments626.9K3.24M+417.0%
Retail attention 4 of 4 signals quiet
Google Trends18/100quiet
News, 30 days12 articlesquiet
Call/put OI1.10quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Four of five funds (Renaissance initiating, Citadel +153%, Bridgewater +89%, Two Sigma +417%) accumulated simultaneously at a ~$78 quarter-end mark, with no fund trimming. The pattern looks like consensus-building through the mid-$80s window when MDT was pricing in diabetes-spin uncertainty and softer-than-feared Hugo RAS cadence. Three of the four are quant books, so weight with care — but the across-the-board direction is harder to dismiss. Catalyst retail hasn't priced: fiscal Q2 2027 on Nov 17 is the first full quarter of Affera / pulsed-field ablation revenue, and PFA share-of-wallet versus J&J has run ahead of the sell-side model.

What would prove it wrong

PFA ablation volumes miss, or the Diabetes spin-off clears at a lower-than-expected transaction value and the stub multiple compresses. The Nov 17 print is the proof point either way.

#2

PCG

PG&E Corporation
UtilitiesMkt cap $32.3BNext earnings Feb 11, 2027
Price
$12.63
Est. fund entry
$16.82-24.9%
Shares held
26.1M
Position value
$438.8M
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies—646.4KNew position
Bridgewater Associates24.5K5.93M+24078.9%
Two Sigma Investments7.06M19.5M+176.5%
Retail attention 4 of 4 signals quiet
Google Trends15/100quiet
News, 30 days14 articlesquiet
Call/put OI1.00quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Three funds — Two Sigma +176% ($328M), Bridgewater turning a 24k-share toe-dip into 5.93M shares ($100M), Renaissance initiating 646k — added at ~$16.80 average, and the stock has since drifted to $12.63 on wildfire-season risk-off. That is institutional entry minus 25%, which is unusual. PCG just released Q3 2026 on Oct 22 with $0.34 diluted EPS, dividend intact, capex plan intact — no catastrophic reset. Catalyst retail hasn't priced: a benign wildfire-season close plus the next CPUC general rate case decision in Q1 2027 can re-rate the stock back toward where the smart money bought.

What would prove it wrong

A major utility-caused fire, Wildfire Fund legislation getting unwound, or an adverse CPUC ruling on allowed ROE. Any of those re-opens the equity-raise overhang that pinned the stock through 2019-2021.

#3

HAL

Halliburton Company
EnergyMkt cap $29.9BNext earnings Jan 20, 2027
Price
$34.92
Est. fund entry
$33.95+2.9%
Shares held
8.41M
Position value
$285.5M
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies—616.1KNew position
Bridgewater Associates28.7K1.59M+5441.4%
Two Sigma Investments2.12M6.20M+191.9%
Retail attention 3 of 4 signals quiet
Google Trends17/100quiet
News, 30 days22 articlesbusy
Call/put OI1.30quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Three funds — Two Sigma +192% ($211M), Bridgewater building a near-nothing position to $54M, Renaissance initiating — added through Q2 at a ~$34 average, essentially where the stock trades today after the Oct 20 Q3 beat. Positioning rhymes with the broader slow-money oilfield-services buildup: SLB, TechnipFMC, and NOV all show up on multiple funds. The post-earnings reaction was muted because the sector remains unloved, which is the point. Catalyst retail hasn't priced: management guided 2027 operating margins to 15% and mid-single-digit revenue growth without assuming a North America fracking recovery — if the North America drilling trough is actually behind us, the whole services complex re-rates.

What would prove it wrong

An OPEC+ supply surge or crude breaking back below $55 snaps the margin thesis. Severance charges continuing into 2027 would also signal demand is softer than guided.

#4

ZTS

Zoetis Inc.
Health CareMkt cap $36.6BNext earnings Nov 5, 2026
Price
$81.03
Est. fund entry
$71.86+12.8%
Shares held
3.82M
Position value
$274.8M
Funds that added
FundPrior sharesShares nowChange
Citadel Advisors774.8K3.69M+376.3%
Bridgewater Associates50.7K134.2K+164.5%
Retail attention 4 of 4 signals quiet
Google Trends14/100quiet
News, 30 days9 articlesquiet
Call/put OI0.90quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Citadel added +376% ($265M) and Bridgewater +165% at a ~$72 average, both buying into the aftermath of the May 2026 guidance cut that took the stock down 21.5%. The signature is classic post-dislocation value: the funds moved after US companion-animal softness and GLP-1-for-pets fears repriced the name, not before. The stock has since recovered to $81 but still trades below the pre-cut trend line. Catalyst retail hasn't priced: Librela/Solensia comps turn easier in Q4 2026, the Simparica Trio label expansion is in-flight, and the Nov 5 Q3 print is the first chance to re-anchor the growth narrative if US companion-animal revenue returns to positive year-over-year.

What would prove it wrong

Q3 on Nov 5 prints another negative US companion-animal number, which would validate the structural-decline bear case. Or a credible GLP-1-for-pets Phase 2 readout from a competitor compresses the terminal multiple.

#5

LEN

Lennar Corporation
Consumer DiscretionaryMkt cap $22.7BNext earnings Dec 15, 2026
Price
$84.92
Est. fund entry
$90.49-6.2%
Shares held
13.1M
Position value
$1.19B
Funds that added
FundPrior sharesShares nowChange
Berkshire Hathaway10.1M13.1M+29.8%
Retail attention 4 of 4 signals quiet
Google Trends21/100quiet
News, 30 days14 articlesquiet
Call/put OI1.00quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Berkshire added +29.8% to its Lennar Class A position (10.1M → 13.1M shares, ~$1.1B at quarter-end) at a ~$90 average while the stock sits at $84.92 today — a Buffett-exception single-fund block that we count under the Berkshire rule. Buffett's cycle call this year — airlines plus homebuilders — reads as cyclical conviction rather than a thematic bet. Lennar's land-light model carries the lowest capital-at-risk profile among the big builders, which is the shape of risk you want to add during a down-cycle. Catalyst retail hasn't priced: the Dec 15 fiscal Q4 print lands against the backdrop of mortgage rates finally retracing below 6%, and the order-growth inflection typically shows up before the earnings beat does.

What would prove it wrong

A renewed rate backup to 7%+ or a credit-cycle event in regional banks curtailing warehouse lending invalidates the setup. The fiscal Q4 guide of $1.30-$1.65 EPS has already been reset lower, so there is no cushion for a sell-through miss.

All scans

Based on public SEC 13F filings. Funds file them up to 45 days after each quarter ends, so they show positions at quarter-end, not today. Average entry prices are estimates (filing value ÷ shares) — 13F filings don't report cost basis. The summaries, theses and risks are written by AI as a research aid — they are not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Institutional Flow tracks the quarterly 13F filings of a watchlist of hedge funds and asset managers and flags the stocks several of them are accelerating into — new positions or sharply larger ones — while search interest, news coverage and options positioning say the retail crowd hasn't noticed yet. It is free, and a new scan is posted every Saturday by 9:00 AM ET. How to read Institutional Flow →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartCreate a free account

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.